Thomas Spector
- Physiology top 1%
- Adenosine and Purinergic Signaling 6
- Biochemistry top 2%
- Molecular Biology top 5%
- Biochemical and Molecular Research 17
- Porphyrin Metabolism and Disorders 4
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid 5
- Clinical Biochemistry top 2%
-
- Colorectal Cancer Treatments and Studies 10
-
- HIV/AIDS drug development and treatment 9
-
- Herpesvirus Infections and Treatments 5
-
- Metal-Catalyzed Oxygenation Mechanisms 4
- Co-authors
- Vincent MasseyRobert E. ParksRam P. AgarwalJoan A. HarringtonThomas A. KrenitskyDavid PorterWillard W. HallLarry G. Howell
- Journals
- Biochemical Pharmacology (26 papers)Analytical Biochemistry (6 papers)Journal of Biological Chemistry (4 papers)
- Partner nations
- United StatesRussiaCanada
In The Last Decade
Thomas Spector
61 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Physiology 309
- Biochemistry 263
- Molecular Biology 1.9k
- Nephrology 193
- Clinical Biochemistry 165
Countries citing papers authored by Thomas Spector
This map shows the geographic impact of Thomas Spector's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Spector with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Spector more than expected).
Fields of papers citing papers by Thomas Spector
This network shows the impact of papers produced by Thomas Spector. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Spector. The network helps show where Thomas Spector may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Spector, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 7 | |
| 2 | 2013 | 176 | |
| 3 | 2010 | 9 | |
| 4 | 2006 | 60 | |
| 5 | 2000 | 21 | |
| 6 | 2000 | 9 | |
| 7 | 1996 | 17 | |
| 8 | 1995 | 14 | |
| 9 | 1994 | 14 | |
| 10 | 1994 | 13 | |
| 11 | 5-Ethynyluracil (776C85): modulation of 5-fluorouracil efficacy and therapeutic index in rats bearing advanced colorectal carcinoma. | 1994 | 95 |
| 12 | 1993 | 88 | |
| 13 | 1992 | 54 | |
| 14 | 1991 | 6 | |
| 15 | 1991 | 26 | |
| 16 | 1989 | 45 | |
| 17 | 1989 | 3 | |
| 18 | 1989 | 10 | |
| 19 | 1987 | 24 | |
| 20 | 1987 | 22 |
About Thomas Spector
Thomas Spector is a scholar working on Chemical Health and Safety, Physiology and Nephrology, having authored 61 papers that have together received 3.9k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (17 papers), Colorectal Cancer Treatments and Studies (10 papers), HIV/AIDS drug development and treatment (9 papers), Adenosine and Purinergic Signaling (6 papers), Herpesvirus Infections and Treatments (5 papers), Gout, Hyperuricemia, Uric Acid (5 papers), Porphyrin Metabolism and Disorders (4 papers) and Metal-Catalyzed Oxygenation Mechanisms (4 papers). The work is most often cited by research in Physiology (309 citations), Biochemistry (263 citations) and Molecular Biology (1.9k citations). Thomas Spector has collaborated with scholars based in United States, Russia and Canada. Frequent co-authors include Vincent Massey, Robert E. Parks, Ram P. Agarwal, Joan A. Harrington, Thomas A. Krenitsky, David Porter, Willard W. Hall, Larry G. Howell, Robert D. Levin and C. G. Lis. Their work appears in journals such as Biochemical Pharmacology, Analytical Biochemistry, Journal of Biological Chemistry, Cancer Chemotherapy and Pharmacology and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.